0000899243-23-015150.txt : 20230609 0000899243-23-015150.hdr.sgml : 20230609 20230609160526 ACCESSION NUMBER: 0000899243-23-015150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230607 FILED AS OF DATE: 20230609 DATE AS OF CHANGE: 20230609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BESHAR LUKE M CENTRAL INDEX KEY: 0001192128 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40657 FILM NUMBER: 231005229 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE STREET 2: 3RD FLOOR CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Omega Therapeutics, Inc. CENTRAL INDEX KEY: 0001850838 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: (617) 949-4360 MAIL ADDRESS: STREET 1: 140 FIRST STREET, SUITE 501 CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-07 0 0001850838 Omega Therapeutics, Inc. OMGA 0001192128 BESHAR LUKE M C/O OMEGA THERAPEUTICS, INC. 140 FIRST STREET, SUITE 501 CAMBRIDGE MA 02141 1 0 0 0 0 Stock Option (Right to Buy) 8.39 2023-06-07 4 A 0 18118 0.00 A 2033-06-06 Common Stock 18118 18118 D The options vest and become exercisable on the earlier of (i) the date of the Issuer's next annual meeting of stockholders and (ii) the first anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. /s/ Barbara Chan as Attorney-in-Fact for Luke M. Beshar 2023-06-09